Transient global ischemia induces selective hippocampal pyramidal neuronal death. Under conditions of severe ischemic hypoxia, hypoxia-inducible factor-1a (HIF-1a) induces apoptosis. Exendin-4 (Ex-4), the glucagon-like peptide-1 receptor (GLP-1R) agonist, provides neuroprotection against brain damage after cerebral ischemia. We investigated the relationship between Ex-4 and HIF-1a by examining Ex-4-induced changes in HIF-1a expression in the gerbil hippocampus following global brain ischemia (in vivo) and in neuroblastoma cells (SH-SY5Y) and cortical primary neurons (in vitro). Twice-daily administration of Ex-4 (1 lg/kg) for 3 days after ischemia (30 min before and 30 min after ischemia on the day of surgery and 2 more days) decreased the number of Fluoro-Jade B-stained cells in the CA1 pyramidal region of the hippocampus of the ischemic brain. Western blot analysis indicated a significant decrease in HIF-1a expression in the ischemic compared with the Sham brain following Ex-4 treatment. These in-vivo results were confirmed in vitro in SH-SY5Y cells and primary cortical neurons treated with 100 nM of Ex-4 under hypoxic conditions (0.1% > O 2 ). We found that Ex-4 decreased the HIF-1a expression in the SH-SY5Y cell line and primary cortical neurons under hypoxic conditions, and this effect was reversed by cotreatment with exendin (9-39), a GLP-1R antagonist. These results suggest that HIF-1a may be involved in the neuroprotective effect of Ex-4 in the hypoxia-damaged brain.
Introduction
Transient global ischemia, often the result of oxygen and glucose deprivation during cardiac arrest, causes selective pyramidal cell death in the CA1 region of the hippocampus [1] , which may lead to severe neurological or neurobehavioral dysfunction [2] . Although several attempts have been made, no effective treatment for global ischemia is available [3] .
Glucagon-like peptide-1 (GLP-1) is a hormone produced by intestinal L-cells in the gastrointestinal tract that responds to food intake and stimulates glucose-dependent insulin secretion [4] . GLP-1 and its receptor (GLP-1R) are synthesized in the brain, including the hippocampus [5] , and modulate neuronal activity, protect against neuronal damage induced by various insults, and are involved in learning and memory [6, 7] . Therefore, GLP-1R could serve as a therapeutic target for neurodegenerative and cognitive disorders in the brain [6] .
Exendin-4 (Ex-4), a GLP-1R agonist, is a 39-amino acid residue peptide originally isolated from the saliva of the Gila monster (Heloderma suspectum) [8] . Ex-4 and GLP-1 can stimulate pancreatic b-cell proliferation, inhibit b-cell apoptosis [7, 9] , and protect cultured hippocampal neurons from apoptotic cell death caused by various insults through the cAMP/CREB signaling pathway [10, 11] . Although Ex-4 has been shown to provide neuroprotection following transient focal cerebral ischemia in mice and transient global ischemia in gerbils [12, 13] , its role in cerebral ischemia is not well understood.
Cerebral ischemia triggers the accumulation of hypoxiainducible factor-1a (HIF-1a) [14] . However, the function of HIF-1a and some of its target genes is unclear and speculative. HIF-1a is considered to regulate prosurvival and prodeath pathways in the nervous system [15] . Severe and prolonged hypoxia may transform HIF-1a from an adaptive phenotype (HIF-1a-HIF-1b complex) into a pathological phenotype (HIF-1a binding with p53 to become the HIF-1a-p53 complex), which causes cell death through apoptosis [16, 17] . Thus, the expressional change in HIF-1a may be a critical event determining the consequences of cerebral ischemia.
The present study investigated the Ex-4-induced change in HIF-1a expression in the hippocampus following cerebral ischemia in the gerbil (in vivo). Moreover, we confirmed our in-vivo findings in an in-vitro experiment using the neuroblastoma cell line SH-SY5Y and primary cortical neurons under hypoxic conditions. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (www.neuroreport.com). [10, 12] . All animals were intraperitoneally administered vehicle or Ex-4 30 min before and 30 min after surgery. Then, the gerbils were administered Ex-4 or vehicle twice daily for 2 days following surgery. Transient global ischemia and tissue preparation were performed according to the methods of the previous study [13] . We occluded bilateral common carotid arteries for 7 min. Animals were killed on day 7 after surgery for immunohistochemical (n = 4 in each group) or Western blot analyses (n = 4 in each group). Fixed brain with 4% paraformaldehyde in 0.1 M phosphate buffer was serial coronal sectioned in 30-mm thickness on a freezing microtome (Leica, Wetzlar, Germany).
Materials and methods

Histochemistry
For the immunohistochemical detection of NeuN and GLP-1R and Fluoro-Jade B staining in the CA1 region of the hippocampus, four coronal brain sections were selected every 10th section across the same region of interest in each animal (between -1.22 and -3.08 mm relative to the bregma). Immunohistochemistry and Fluoro-Jade B staining were performed according to the previous studies [13, 18] . We used one of the following primary antibodies for immunohistochemistry: mouse monoclonal anti-NeuN (1 : 1000 dilution; Chemicon, Billerica, Massachusetts, USA) or rabbit polyclonal antihuman GLP-1R (1 : 500 dilution; Santa Cruz Biotechnology, Santa Cruz, California, USA) antibodies and one of the following secondary antibodies: mouse monoclonal anti-NeuN (1 : 1000 dilution; Chemicon) or rabbit polyclonal anti-human GLP-1R (1 : 500 dilution; Santa Cruz Biotechnology) antibodies.
To determine the number of NeuN-stained or FluoroJade-B-stained cells/mm 2 , we measured the total area of the CA1 region using Stereo Investigator software (Microbrightfield, Williston, Vermont, USA) and then estimated the number of stained cells. The number of stained cells was presented as stained cell number per 1 mm 2 of the CA1 region (stained cells/mm 2 ).
Cell culture and reagent
Human neuroblastoma SH-SY5Y cells were obtained from ATCC (Manassas, Virginia, USA). The cells were maintained in Dulbecco's modified Eagle medium (Wel-GENE, Daegu, Korea) supplemented with 10% fetal bovine serum (HyClone, Lagon, Utah, USA) and 100 U/ml penicillin/streptomycin (Cellgro, Manassas, Virginia, USA) in a 5% CO 2 incubator.
Primary cortical neurons were prepared from C57/BL6 mouse embryos at 14 days' gestation in cold Leibovitz's L-15 Medium (WelGENE). Primary cell collection from the cortex was performed as described previously [19] .
Hypoxic conditions
For in-vitro ischemia, hypoxic conditions were generated using a Modular Incubator Chamber (Billups-Rothenberg Inc., Del Mar, California, USA) with continuous flushing with a humidified mixture of 95% N 2 and 5% CO 2 . Euglycemic conditions were mimicked using low-glucose Dulbecco's modified Eagle medium (Sigma) and 1 Â 10 6 cells/ml were plated onto 60-mm plates. Cells were assigned to the following groups: the Normoxia group, the normoxiatreated 100 nM Ex-4 group (Normoxia-Ex-4 group), the Hypoxia group, the hypoxia-treated 100 nM Ex-4 group (Hypoxia-Ex-4 group), and the hypoxia-treated 100 nM Ex-4 and 200 nM Ex(9-39) (Bachem Americas Inc., Torrance, California, USA) [Hypoxia-Ex-4-Ex(9-39) group]. Cells were incubated for 2 h and lysed to obtain their proteins. Each experiment was conducted at least in triplicate.
Western blotting analysis
The hippocampal tissue or whole-cell lysates were homogenized in lysis buffer. After centrifugation (12 000 rpm for 30 min at 41C), the supernatant was used for immunoblotting.
Western blotting analysis was carried out according to a previous study [20] . We used the following primary antibodies: mouse monoclonal anti-human HIF-1a (1 : 1000 dilution; BD Science, San Jose, California, USA), mouse monoclonal anti-Bax (1 : 200 dilution; Santa Cruz Biotechnology), mouse monoclonal anti-Bcl-2 (1 : 200 dilution; Santa Cruz Biotechnology), rabbit polyclonal anti-human GLP-1R (1 : 1000 dilution; Santa Cruz Biotechnology), rabbit monoclonal anti-b-actin (1 : 10 000 dilution; Cell Signaling, Danvers, Massachusetts, USA), and mouse monoclonal anti-a-tubulin (1 : 10 000 dilution; Sigma). Images were scanned and analyzed semiquantitatively using ImageJ software 1.39u (Wayne Rasband, National Institutes of Health, Bethesda, Maryland, USA). Please refer to the Supplemental digital content 1 (http:// links.lww.com/WNR/A257) for details of antibodies.
Quantification and statistical analysis
A one-way analysis of variance was used to determine overall significance, followed by post-hoc Tukey's tests to 
Results
GLP-1 receptors were observed in the pyramidal neurons of the hippocampus (Supplemental digital content 2, http://links.lww.com/WNR/A257). At 7 days following global ischemia, we detected surviving neurons and apoptotic cells. In the Sham group, NeuN-positive neurons were abundant (1467±27.0/mm 2 ) and no Fluoro-Jade B cells were found in the CA1 region (Supplemental digital content 3, http://links.lww.com/WNR/A257 and Fig. 1a-f ). In the Ischemia group, NeuN-positive cells were observed in 57.8% of the CA1 region (848.1±116.9/mm 2 ; P < 0.0001) compared with the Sham group, and several Fluoro-Jade B cells were detected in the pyramidal layer of the CA1 region (451.6±60.97/mm 2 ; Fig. 1g and h ). In the Sham-Ex-4 group, the NeuN-immunoreactive cells (1245±63.55/mm 2 ) were significantly greater than those observed in the Ischemia group (P < 0.01), and the Fluoro-Jade B-stained cells (153.3±50.05/mm 2 ) were significantly smaller than those of the Ischemia group (P < 0.001; Fig. 1g and h ).
To determine whether Ex-4 altered the level of Bcl-2 family proteins in the brain, we examined Bcl-2 and Bax protein expression. The Bcl-2/Bax ratio was significantly lower in the Ischemia group than in the Sham group (Ischemia group, 1.01 vs. Sham group, 6.39; P < 0.001), whereas Ex-4 markedly reversed the Bcl-2/Bax ratio (Ischemia-Ex-4 group, 6.40 vs. Ischemia group, 1.01; P < 0.05; Fig. 1i and j).
Our investigation of the effect of Ex-4 treatment on HIF1a expression in the hippocampus following global brain ischemia showed that HIF-1a expression was significantly higher in the Ischemia group than in the Sham group on day 7 following ischemia (P < 0.001). Treatment with Ex-4 significantly reduced HIF-1a expression in the Ischemia group (P < 0.05; Fig. 2a ).
The effect of Ex-4 treatment on HIF-1a expression was then investigated in human neuroblastoma cells (SH-SY5Y) cultured under normoxic (21% O 2 ) or hypoxic (0.1% > O 2 ) conditions. First, we confirmed that SH-SY5Y cells expressed the GLP-1 receptor (Fig. 2b, upper panel) . At the protein level, HIF-1a was significantly increased in SH-SY5Y cells in the Hypoxic compared with the Normoxia group (P < 0.001; Fig. 2b ). Treatment with Ex-4 significantly decreased the expression of HIF-1a in SH-SY5Y cells under hypoxic conditions (P < 0.05; Fig. 2b, lower panel) .
We exposed SH-SY5Y cells and primary cortical neurons to Ex(9-39), a GLP-1R antagonist. First, we examined the effect of Ex(9-39) on the expression of HIF-1a in hypoxic SH-SY5Y cells. Figure 3a shows that the expression of HIF-1a decreased in the Hypoxia-Ex-4 group and that Ex(9-39) reversed the downregulation of HIF-1a expression. Our experiment using primary cortical neurons confirmed that under hypoxic conditions, primary cortical neurons express GLP-1R (Fig. 3b, upper panel) . Moreover, we found that Ex-4 treatment downregulated HIF-1a expression and that this effect was reversed by Ex(9-39).
Discussion
The present study found that Ex-4, a GLP-1R agonist, exerted a neuroprotective effect against cell death in the gerbil hippocampus after global brain ischemic, while simultaneously downregulating HIF-1a expression, as shown by Western blotting analysis. Furthermore, we found that Ex-4 decreased HIF-1a expression in the SH-SY5Y neuroblastoma cell line under hypoxic conditions and that Ex(9-39), a GLP-1R antagonist, reversed the Ex-4-induced change in HIF-1a expression in SH-SY5Y cells and primary cortical neurons. We believe that our study is the first to show that HIF-1a expression is regulated by Ex-4 in the brain and in neuronal cell lines.
In this study, we treated Ex-4 30 min before and after ischemia surgery and twice daily for 2 days after surgery.
Lee et al. [13] reported that administration of Ex-4 to Mongolian Gerbil 2 h before surgery and 1 h after reperfusion has neuroprotective effects against cell death in the hippocampus. In addition, Teramoto et al. [12] reported that injection of Ex-4 at 0 h after middle cerebral artery occlusion produced the best effects with respect to infarct volume in the brain. These previous studies have shown that the neuroprotective effect of Ex-4 was produced when it was treated before surgery or at least immediately after surgery. One possible speculation is that the administration before Ischemia or Ex-4 plus Ischemia may possibly reduce the ischemic event compared with the group without Ex-4.
Our study showed that Ex-4 treatment inhibited the expression of HIF-1a in the brain following global ischemia and in hypoxic cells. Recently, Jia et al. [21] investigated the role of HIF-1a in mediating the beneficial effects of Ex-4. They showed that Ex-4 treatment regulated the expression of HIF-1a mRNA and protein in rat islet cell culture. However, no previous study has shown that Ex-4 regulates HIF-1a expression in the animal brain and neuronal cell lines. The results of the present study suggest that HIF-1a may play a role in Exendin-4 (Ex-4)-stimulated decrease in the expression of hypoxia-inducible factor-1a (HIF-1a) is mediated through a glucagon-like peptide-1 (GLP-1) receptor-dependent pathway. Ex(9-39) inhibited Ex-4-induced downregulation of HIF-1a expression in SH-SY5Y cells (a) and primary cortical neurons (b) under hypoxic conditions. The upper panels show representative blots. The bar graphs represent summarized data derived from three independent experiments after being normalized to a-tubulin bands expressed as a mean percentage±SEM. (a) *P < 0.001 vs. the Normoxia group, **P < 0.05 vs. the Hypoxia group, and ***P < 0.01 vs. the Hypoxia-Ex-4 group. (b) *P < 0.001 vs. the Normoxia group, **P < 0.01 vs. the Hypoxia group, and ***P < 0.05 vs. the Hypoxia-Ex-4 group.
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Ex-4 regulation of the neuronal cell response. Moreover, we used a GLP-1 receptor antagonist to show that the Ex-4-induced change in HIF-1a protein expression was the direct result of GLP-1R signaling, suggesting that the Ex-4-stimulated reduction in HIF-1a expression is mediated by a GLP-1R-dependent pathway.
The present study found that Ex-4 treatment inhibited cell death and simultaneously decreased HIF-1a expression in the hippocampus after global brain ischemia. HIF1a has been described as a master regulator of the cellular response to hypoxia [15] . Under slight hypoxia, HIF-1a may play an antiapoptotic role by activating the expression of survivin and repressing caspase-3 [22] . Under conditions of severe hypoxia, HIF-1a in the brain may have a deleterious effect during acute ischemic insult because the neuroprotective effects of HIF-1a cannot fully compensate for its apoptosis-inducing effects. The absence of HIF-1a reduced the expression of genes involved in apoptosis in a global ischemia and reperfusion model in a HIF-1a gene knockout mouse and partly protected nerve cells [23] . Recently, Li et al. [24] reported that 2-methoxystradiol, an estradiol derivative and HIF-1a inhibitor, decreased apoptosis. Consistent with the findings of Li et al. [24] , our study showed that HIF-1a expression decreased simultaneously with the Ex-4 neuroprotective effect in the hippocampus following global ischemia, suggesting that HIF-1a may play a proapoptotic role in this ischemia model. However, our findings do not provide conclusive evidence that HIF-1a induces cell death and is the final mediator of the Ex-4-induced neuroprotective effect. Further investigations should be carried out to determine whether the neuroprotective effects of Ex-4 are dependent on HIF-1a.
Conclusion
Our results suggest that Ex-4 inhibits neuronal cell death in the CA1 region of the hippocampus in a gerbil global ischemia model. Furthermore, we showed that Ex-4 downregulates HIF-1a expression under hypoxic conditions in vivo (gerbil transient ischemia model) and in vitro (SH-SY5Y cells and primary cortical neurons). These findings suggest that Ex-4 regulates the expression of HIF-1a in neuronal cells and that the transcriptional factor may play an important role in the neuroprotective effect of Ex-4 in hypoxia-damaged cells.
